Abstract
Hematopoietic stem cells (HSCs) are a promising target for gene therapy, however, the low efficiencies of gene transfer using currently available vectors face practical limitations. We have recently developed a novel and efficient gene transfer agent, namely recombinant Sendai virus (SeV), and we have here characterized SeV-mediated gene transfer to human cord blood (CB) HSCs and primitive progenitor cells (PPC) using the jelly fish green fluorescent protein (GFP) gene. Even at a relatively low titer (10 multiplicity of infections), SeV achieved highly efficient GFP expression in CB CD34+ cells (85.5±5.8%), as well as more immature CB progenitor cells, CD34+AC133+ (88.2±3.7%) and CD34+CD38− (84.6±5.7%) cells, without cytokines prestimulation, that was a clear contrast to the features of gene transfer using retroviruses. SeV-mediated gene transfer was not seriously affected by the cell cycle status. In vitro cell differentiation studies revealed that gene transfer occurred in progenitor cells of all lineages (GM-CFU, 73.0±11.1%; BFU-E, 24.7±4.0%; Mix-CFU, 59±4.0%; and total, 50.0±7.0%). These findings show that SeV could prove to be a promising vector for efficient gene transfer to CB HSCs, while preserving their ability to reconstitute the entire hematopoietic series.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Yonemitsu Y et al. Efficient gene transfer to airway epithelium using recombinant Sendai virus. Nat Biotechnol 2000; 18: 970–973.
Masaki I et al. Recombinant Sendai virus-mediated gene transfer to vasculature: a new class of efficient gene transfer vector to the vascular system. FASEB J 2001; 15: 1294–1296.
Shiotani A et al. Skeletal muscle regeneration after insulin-like growth factor I gene transfer by recombinant Sendai virus vector. Gene Ther 2001; 8: 1043–1050.
Yamashita A et al. Fibroblast growth factor-2 determines severity of joint disease in adjuvant-induced arthritis in rats. J Immunol 2002; 168: 450–457.
Markwell MA, Svennerholm L, Paulson JC . Specific gangliosides function as host cell receptors for Sendai virus. Proc Natl Acad Sci USA 1981; 78: 5406–5410.
Moyer SA, Baker SC, Lessard JL . Tubulin: a factor necessary for the synthesis of both Sendai virus and vesicular stomatitis virus RNAs. Proc Natl Acad Sci USA 1986; 83: 5405–5409.
Gothot A et al. Assessment of proliferative and colony-forming capacity after successive in vitro divisions of single human CD34+ cells initially isolated in G0 . Exp Hematol 1998; 26: 562–570.
Becker PS et al. Adhesion receptor expression by hematopoietic cell lines and murine progenitors: modulation by cytokines and cell cycle status. Exp Hematol 1999; 27: 533–541.
Gonzalez R et al. Increased gene transfer in acute myeloid leukemic cells by an adenovirus vector containing a modified fiber protein. Gene Ther 1999; 6: 314–320.
Huang S, Endo RI, Nemerow GR . Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and lymphocytes facilitates adenovirus-mediated gene delivery. J Virol 1995; 69: 2257–2263.
Bodine DM, McDonagh KT, Seidel NE, Nienhuis AW . Survival and retrovirus infection of murine hematopoietic stem cells in vitro: effects of 5-FU and method of infection. Exp Hematol 1991; 19: 206–212.
Tumas DB et al. High-frequency cell surface expression of a foreign protein in murine hematopoietic stem cells using a new retroviral vector. Blood 1996; 87: 509–517.
Cavazzana-Calvo M et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000; 28: 669–672.
Luther-Wyrsch A et al. Stable transduction with lentiviral vectors and amplification of immature hematopoietic progenitors from cord blood of preterm human fetuses. Hum Gene Ther 2001; 12: 377–389.
Gothot A et al. Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34+ cells in non-obese diabetic/severe combined immune-deficient mice. Blood 1998; 92: 2641–2649.
Kato A et al. The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J 1997; 16: 578–587.
Bitzer M et al. Sendai virus infection induces apoptosis through activation of caspase-8 (FLICE) and caspase-3 (CPP32). J Virol 1999; 73: 702–708.
Kato A et al. Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells 1996; 1: 569–579.
Sakai Y et al. Accommodation of foreign genes into the Sendai virus genome: sizes of inserted genes and viral replication. FEBS Lett 1999; 456: 221–226.
Kolakofsky D et al. Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited. J Virol 1998; 7: 891–899.
Fuerst TR, Niles EG, Studier FW, Moss B . Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci USA 1986; 83: 8122–8126.
Yonemitsu Y, Kaneda Y . Hemagglutinating virus of Japan-liposome-mediated gene delivery to vascular cells. In: Baker AH (ed.). Molecular Biology of Vascular Diseases. Methods in Molecular Medicine. Humana Press: Clifton, 1999, pp 295–306.
Jordan CT, Yamasaki G, Minamoto D . High-resolution cell cycle analysis of defined phenotypic subsets within primitive human hematopoietic cell populations. Exp Hematol 1996; 24: 1347–1355.
Acknowledgements
We thank Dr Kusuo Sanada for providing cord blood samples. This study was supported by a Grant of Promotion of Basic Scientific Research in Medical Frontier of the Organization for Pharmaceutical Safety and Research, and by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. M Ohara provided language assistance.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jin, C., Kusuhara, K., Yonemitsu, Y. et al. Recombinant Sendai virus provides a highly efficient gene transfer into human cord blood-derived hematopoietic stem cells. Gene Ther 10, 272–277 (2003). https://doi.org/10.1038/sj.gt.3301877
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301877
Keywords
This article is cited by
-
Sendai virus, an RNA virus with no risk of genomic integration, delivers CRISPR/Cas9 for efficient gene editing
Molecular Therapy - Methods & Clinical Development (2016)
-
Transplantation of sendai viral angiopoietin-1-modified mesenchymal stem cells for ischemic limb disease
Angiogenesis (2010)
-
Sendai viral vector mediated angiopoietin-1 gene transfer for experimental ischemic limb disease
Angiogenesis (2009)
-
Optimization of adenovirus serotype 35 vectors for efficient transduction in human hematopoietic progenitors: comparison of promoter activities
Gene Therapy (2005)
-
Efficient and stable Sendai virus-mediated gene transfer into primate embryonic stem cells with pluripotency preserved
Gene Therapy (2005)